Erectile Dysfunction Progression After Percutaneous Coronary Angiography: Is Residual SYNTAX Score a Predictive Marker
1 other identifier
observational
100
1 country
1
Brief Summary
Participant Information Sheet Dear Participant, Investigators would like to invite participants to participate in a research study and explain what it involves. Please take a few moments to read the following information carefully. If you have any questions, feel free to ask us at any time. What is this study about? This study aims to understand how coronary angiography (a heart procedure you've recently had) may affect erectile function over time. Investigators are especially interested in whether the degree of blockage in participants' heart vessels and how well participants were treated during the procedure affect erectile health. What will participants be asked to do? If participants agree to take part: Investigators will ask participants to answer a short questionnaire with five questions about their erectile function. This will happen once while participants recover in the hospital and again 6 months later. Each question is rated on a simple scale from 0 to 5. Investigators will also collect some medical information, such as your age, weight, height, blood test results, details about your heart condition, other health problems, and the medications participants are taking. All information will be kept confidential and used only for scientific purposes. Participants' identities will not be revealed in any part of the study. Do participants have to take part? No. Participation is completely voluntary. Participants can choose not to take part, and you can also stop at any time without giving a reason. Participants' decisions will not affect their medical care in any way. Will there be any extra tests or costs? No. This study does not involve extra tests beyond regular medical care, such as blood tests or heart monitoring, and participation is free. How long will the study last? The study will last approximately one year. Once it's completed, participants are welcome to ask for the results from our institution. Who is conducting the study? The study is being conducted by: Assist Prof Dr. Timucin Sipal (Urology Department) Assist Prof Dr. Caglar Alp (Cardiology Department) You can contact them anytime using the phone number we have provided. What happens next? If participants are happy to participate, please sign the attached consent form. Sincerely, The Research Team
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 14, 2025
CompletedFirst Submitted
Initial submission to the registry
May 30, 2025
CompletedFirst Posted
Study publicly available on registry
June 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedJune 13, 2025
June 1, 2025
7 months
May 30, 2025
June 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Erectile functioning changes following percutaneous coronary intervention from baseline through 6 months
Participants' answers will decrease or increase from the baseline score of 0 to 25 on the IIEF questionnaires following percutaneous coronary intervention after a heart attack.
from February 2025 to September 2025
Study Arms (2)
Residual Syntax score more than 20%
Residual Syntax score less than and equal 20%
Eligibility Criteria
Male participants who have a heart attack and undergo percutaneous coronary intervention in our institutions and survive the event.
You may qualify if:
- Having a First heart attack
You may not qualify if:
- History of previous coronary intervention
- Neurological condition
- Previous pelvic surgery
- Aged less than 20 and more than 70 years
- Having an additional heart attack during the follow-up period
- Excluding from the study
- Having no sexual life
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
kirikkale Un'versity medical faculty
Kırıkkale, 71500, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant Professor/ Lecturer
Study Record Dates
First Submitted
May 30, 2025
First Posted
June 8, 2025
Study Start
February 14, 2025
Primary Completion
September 15, 2025
Study Completion
October 1, 2025
Last Updated
June 13, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- approximately at the end of August 2025